Clinical trialNCT06324240RecruitingPhase 1Interventional

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

SponsorEmory UniversityEnrollment18Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+21 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Keerthi Gogineni, MD, MSHP
Emory University Hospital/Winship Cancer Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
Keerthi Gogineni, MD, MSHP
Recruiting
Emory University Hospital Midtown
Atlanta, Georgia, United States
Keerthi Gogineni, MD, MSHP
Recruiting
Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
Keerthi Gogineni, MD, MSHP
Recruiting
Grady Health System
Atlanta, Georgia, United States
Keerthi Gogineni, MD, MSHP
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Dec 2025
Primary completion: 31 Dec 2026
Completion: 31 Dec 2026
Last update posted: 26 Jan 2026
Registered enrollment: 18
Registry id: NCT06324240

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.